The semaglutide plateau troubleshooting guide covers common reasons for stalling, and CagriSema represents a pharmacological solution to that plateau by engaging an entirely new receptor system
GLP-1 medications work primarily by: Because they do not involve surgery, many individuals view GLP-1 medications as a less invasive option for long-term weight management
Peptide Clearance Quick Facts Typical half-life Minutes to a few hours for most peptides Main exception CJC-1295 with DAC (days), not used in the combo Cleared how Enzyme breakdown, kidney filtration, tissue reuse Effect vs molecule Effects often outlast the peptide by days Standard drug tests Do not screen for therapeutic peptides Biggest variables Formulation, dose, kidney/liver function The Short Answer Most therapeutic peptides do not linger
Supports appetite regulation
If the patient can tolerate it, the dose is escalated to 1.7 mg (Wegovy) or 2 mg weekly (Ozempic) for the next four weeks and up to a maximum of 2.4 mg once weekly (Wegovy) afterwards as a maintenance dose